Company: OBA
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001213900-25-109993
Chunk: 101

Company: Oxley Bridge Acquisition Ltd
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 2
Chunk 101
---
 of disclosure controls and procedures must reflect the fact that there are resource
constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls
and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control
deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions
about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under
all potential future conditions. 

Changes in Internal Control over Financial
Reporting

Not applicable.

25

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

To the knowledge of our Management Team, there
is no material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or
against any of our property.

Item 1A. Risk Factors.

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. However,
for risks relating to our operations, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement
and (ii) 2025 Q2 Form 10-Q. As of the date of this Report, there have been no material changes with respect to those risk factors. Any
of these previously disclosed risk factors could result in a significant or material adverse effect on our results of operations or financial
condition. Additional risks not presently known to us or that we currently deem immaterial may also affect our ability to consummate an
initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our
future filings with the SEC.

Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.

Unregistered Sales of Equity Securities 

There were no sales of unregistered securities
during the quarterly period covered by the Report. However, simultaneously with the closing of the Initial Public Offering and pursuant
to the Private Placement Warrants Purchase Agreements, we completed the sale of an aggregate of 6,400,000 Private Placement Warrants to
the Sponsor and Cantor in the Private Placement at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds
to us of $6,400,000. Of those 6,400,000 Private Placement Warrants, the Sponsor purchased 4,200,000 Private Placement W